{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:54:26Z","timestamp":1788310466655,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2023-18-72"],"award-info":[{"award-number":["320.6750.2023-18-72"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province university key laboratory open research project","award":["XZSYSKF2022008"],"award-info":[{"award-number":["XZSYSKF2022008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12010-026-05648-3","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:03:24Z","timestamp":1774857804000},"page":"4863-4879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metformin Induces Ferroptosis and Inhibits Malignant Progression in Diabetic Breast Cancer"],"prefix":"10.1007","volume":"198","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-3873","authenticated-orcid":false,"given":"Changwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"3","key":"5648_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"5648_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","volume":"6","author":"I Wolf","year":"2005","unstructured":"Wolf, I., Sadetzki, S., Catane, R., Karasik, A., & Kaufman, B. (2005). Diabetes mellitus and breast cancer. The Lancet Oncology, 6(2), 103\u2013111. https:\/\/doi.org\/10.1016\/S1470-2045(05)01736-5","journal-title":"The Lancet Oncology"},{"issue":"2","key":"5648_CR3","doi-asserted-by":"publisher","first-page":"e002697","DOI":"10.1136\/bmjdrc-2021-002697","volume":"10","author":"S Pan","year":"2022","unstructured":"Pan, S., Guan, Y., Ma, Y., Cui, Q., Tang, Z., Li, J., & Liu, Z. (2022). Advanced glycation end products correlate with breast cancer metastasis by activating RAGE\/TLR4 signaling. BMJ open diabetes research & care, 10(2), e002697. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002697","journal-title":"BMJ open diabetes research & care"},{"issue":"11","key":"5648_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/onc.2016.324","volume":"36","author":"T Kwak","year":"2017","unstructured":"Kwak, T., Drews-Elger, K., Ergonul, A., Miller, P. C., Braley, A., Hwang, G. H., & Hudson, B. I. (2017). Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. Oncogene, 36(11), 1559\u20131572. https:\/\/doi.org\/10.1038\/onc.2016.324","journal-title":"Oncogene"},{"issue":"11","key":"5648_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.22038\/IJBMS.2021.58825.13069","volume":"24","author":"D Neamati","year":"2021","unstructured":"Neamati, D., Khedri, A., Aberomand, M., Hemmati, A. A., Mohammadzadeh, M., Baghbani, A., K., & Mohammadzadeh, G. (2021). Metformin synergistically increases the anticancer effects of lapatinib through induction of apoptosis and modulation of Akt\/AMPK pathway in SK-BR3 breast cancer cell line. Iranian Journal of Basic Medical Sciences, 24(11), 1529\u20131537. https:\/\/doi.org\/10.22038\/IJBMS.2021.58825.13069","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"12","key":"5648_CR6","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/biom11121888","volume":"11","author":"TYL Huynh","year":"2021","unstructured":"Huynh, T. Y. L., Oscilowska, I., S\u00e1iz, J., Nizio\u0142, M., Baszanowska, W., Barbas, C., & Palka, J. (2021). Metformin Treatment or PRODH\/POX-Knock out Similarly Induces Apoptosis by Reprograming of Amino Acid Metabolism, TCA, Urea Cycle and Pentose Phosphate Pathway in MCF-7 Breast Cancer Cells. Biomolecules, 11(12), 1888. https:\/\/doi.org\/10.3390\/biom11121888","journal-title":"Biomolecules"},{"issue":"1","key":"5648_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-019-1211-2","volume":"38","author":"JC Wang","year":"2019","unstructured":"Wang, J. C., Li, G. Y., Wang, B., Han, S. X., Sun, X., Jiang, Y. N., & Liu, P. J. (2019). Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation. Journal of experimental & clinical cancer research: CR, 38(1), 235. https:\/\/doi.org\/10.1186\/s13046-019-1211-2","journal-title":"Journal of experimental & clinical cancer research: CR"},{"issue":"14","key":"5648_CR8","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1158\/1078-0432.CCR-20-0269","volume":"26","author":"RA Hampsch","year":"2020","unstructured":"Hampsch, R. A., Wells, J. D., Traphagen, N. A., McCleery, C. F., Fields, J. L., Shee, K., & Miller, T. W. (2020). AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 26(14), 3707\u20133719. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0269","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"1","key":"5648_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., & Conrad, M. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13(1), 91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nature Chemical Biology"},{"issue":"7784","key":"5648_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., & Olzmann, J. A. (2019). The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 575(7784), 688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"issue":"4","key":"5648_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","volume":"71","author":"JH Cha","year":"2018","unstructured":"Cha, J. H., Yang, W. H., Xia, W., Wei, Y., Chan, L. C., Lim, S. O., & Hung, M. C. (2018). Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. Molecular Cell, 71(4), 606\u2013620e7. https:\/\/doi.org\/10.1016\/j.molcel.2018.07.030","journal-title":"Molecular Cell"},{"issue":"5","key":"5648_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.14740\/wjon1518","volume":"13","author":"WL Min","year":"2022","unstructured":"Min, W. L., Wang, B. F., Liang, B. B., Zhang, L., Pan, J. Y., Huang, Y., & Ma, Q. Y. (2022). A ROS\/Akt\/NF-\u03baB Signaling Cascade Mediates Epidermal Growth Factor-Induced Epithelial-Mesenchymal Transition and Invasion in Human Breast Cancer Cells. World Journal of Oncology, 13(5), 289\u2013298. https:\/\/doi.org\/10.14740\/wjon1518","journal-title":"World Journal of Oncology"},{"issue":"1","key":"5648_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang, J., Zhou, Y., Xie, S., Wang, J., Li, Z., Chen, L., & Zhou, J. (2021). Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. Journal of experimental & clinical cancer research: CR, 40(1), 206. https:\/\/doi.org\/10.1186\/s13046-021-02012-7","journal-title":"Journal of experimental & clinical cancer research: CR"},{"issue":"1","key":"5648_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biom9010016","volume":"9","author":"S Varghese","year":"2019","unstructured":"Varghese, S., Samuel, S. M., Varghese, E., Kubatka, P., & B\u00fcsselberg, D. (2019). High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells. Biomolecules, 9(1), 16. https:\/\/doi.org\/10.3390\/biom9010016","journal-title":"Biomolecules"},{"issue":"24","key":"5648_CR15","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.4161\/cc.26641","volume":"12","author":"R Wahdan-Alaswad","year":"2013","unstructured":"Wahdan-Alaswad, R., Fan, Z., Edgerton, S. M., Liu, B., Deng, X. S., Arnadottir, S. S., & Thor, A. D. (2013). Glucose promotes breast cancer aggression and reduces metformin efficacy. Cell Cycle (Georgetown Tex), 12(24), 3759\u20133769. https:\/\/doi.org\/10.4161\/cc.26641","journal-title":"Cell Cycle (Georgetown Tex)"},{"issue":"7","key":"5648_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamaoncol.2022.1911","volume":"8","author":"JE Mortimer","year":"2022","unstructured":"Mortimer, J. E., & Seewaldt, V. (2022). Who Will Benefit From Metformin? JAMA oncology, 8(7), 979\u2013981. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1911","journal-title":"JAMA oncology"},{"issue":"35","key":"5648_CR17","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/JCO.23.00296","volume":"41","author":"PJ Goodwin","year":"2023","unstructured":"Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., & Parulekar, W. R. (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 41(35), 5356\u20135362. https:\/\/doi.org\/10.1200\/JCO.23.00296","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"3","key":"5648_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbadis.2014.12.009","volume":"1852","author":"H Sharaf","year":"2015","unstructured":"Sharaf, H., Matou-Nasri, S., Wang, Q., Rabhan, Z., Al-Eidi, H., Abdulrahman, A., A., & Ahmed, N. (2015). Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231. Biochimica Et Biophysica Acta, 1852(3), 429\u2013441. https:\/\/doi.org\/10.1016\/j.bbadis.2014.12.009","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"4","key":"5648_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","volume":"15","author":"WJ Gradishar","year":"2017","unstructured":"Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., & Kumar, R. (2017). NCCN Guidelines Insights: Breast Cancer, Version 1.2017. Journal of the National Comprehensive Cancer Network: JNCCN, 15(4), 433\u2013451. https:\/\/doi.org\/10.6004\/jnccn.2017.0044","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"1","key":"5648_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/cd16-0067","volume":"35","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. (2017). Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers. Clinical Diabetes: A Publication of the American Diabetes Association, 35(1), 5\u201326. https:\/\/doi.org\/10.2337\/cd16-0067","journal-title":"Clinical Diabetes: A Publication of the American Diabetes Association"},{"issue":"7403","key":"5648_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C., Shah, S. P., Chin, S. F., Turashvili, G., Rueda, O. M., Dunning, M. J., & Aparicio, S. (2012). The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature, 486(7403), 346\u2013352. https:\/\/doi.org\/10.1038\/nature10983","journal-title":"Nature"},{"issue":"2","key":"5648_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R., Angeli, F., Bayir, J. P., Bush, H., Conrad, A. I., Dixon, M., & Zhang, S. J., D. D (2017). Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell, 171(2), 273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"issue":"2","key":"5648_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J., Cao, F., Yin, H. L., Huang, Z. J., Lin, Z. T., Mao, N., & Wang, G. (2020). Ferroptosis: past, present and future. Cell Death & Disease, 11(2), 88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death & Disease"},{"issue":"5","key":"5648_CR24","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.3892\/mmr.2017.7563","volume":"16","author":"L Gao","year":"2017","unstructured":"Gao, L., Hu, Y., & Li, J. (2017). Pigment epithelium\u2013derived factor protects human glomerular mesangial cells from diabetes via NOXO1\u2013iNOS suppression. Molecular Medicine Reports, 16(5), 7855\u20137863. https:\/\/doi.org\/10.3892\/mmr.2017.7563","journal-title":"Molecular Medicine Reports"},{"issue":"14","key":"5648_CR25","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. (2022). Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell, 185(14), 2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003","journal-title":"Cell"},{"issue":"2","key":"5648_CR26","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.xcrm.2025.101928","volume":"6","author":"X Shen","year":"2025","unstructured":"Shen, X., Chen, Y., Tang, Y., Lu, P., Liu, M., Mao, T., & Xue, J. (2025). Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. Cell Reports Medicine, 6(2), 101928. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101928","journal-title":"Cell Reports Medicine"},{"issue":"4","key":"5648_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/cac2.12646","volume":"45","author":"C Pottier","year":"2025","unstructured":"Pottier, C., Montero-Ruiz, L., Jehay, R., Wery, C., Baiwir, D., Mazzucchelli, G., & Sounni, N. E. (2025). Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy. Cancer Communications (London England), 45(4), 460\u2013464. https:\/\/doi.org\/10.1002\/cac2.12646","journal-title":"Cancer Communications (London England)"},{"issue":"3","key":"5648_CR28","doi-asserted-by":"publisher","first-page":"e70257","DOI":"10.1002\/ctm2.70257","volume":"15","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y., Zhao, Z., Jiang, C., Nie, C., Xiao, D., Wu, Z., & Jiang, X. (2025). LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF\/USP7 axis. Clinical and Translational Medicine, 15(3), e70257. https:\/\/doi.org\/10.1002\/ctm2.70257","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"5648_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J., & Stockwell, B. R. (2014). The role of iron and reactive oxygen species in cell death. Nature Chemical Biology, 10(1), 9\u201317. https:\/\/doi.org\/10.1038\/nchembio.1416","journal-title":"Nature Chemical Biology"},{"issue":"8","key":"5648_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L., & Gan, B. (2021). Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein & Cell, 12(8), 599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein & Cell"},{"issue":"1","key":"5648_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40164-023-00411-4","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu, X., Zhong, S., Qiu, K., Chen, X., Wu, W., Zheng, J., & Zeng, C. (2023). Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Experimental Hematology & Oncology, 12(1), 47. https:\/\/doi.org\/10.1186\/s40164-023-00411-4","journal-title":"Experimental Hematology & Oncology"},{"issue":"1","key":"5648_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng, X., Jin, X., Ye, F., Liu, X., Yu, B., Li, Z., & Li, Q. (2023). Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Experimental Hematology & Oncology, 12(1), 65. https:\/\/doi.org\/10.1186\/s40164-023-00427-w","journal-title":"Experimental Hematology & Oncology"},{"issue":"7784","key":"5648_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., & Conrad, M. (2019). FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 575(7784), 693\u2013698. https:\/\/doi.org\/10.1038\/s41586-019-1707-0","journal-title":"Nature"},{"issue":"1","key":"5648_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.15-3","volume":"57","author":"MS Ottum","year":"2015","unstructured":"Ottum, M. S., & Mistry, A. M. (2015). Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance. Journal of Clinical Biochemistry and Nutrition, 57(1), 1\u201312. https:\/\/doi.org\/10.3164\/jcbn.15-3","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"issue":"5","key":"5648_CR35","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","volume":"280","author":"MP Wautier","year":"2001","unstructured":"Wautier, M. P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. L. (2001). Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. American Journal of Physiology Endocrinology and Metabolism, 280(5), E685\u2013694. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.5.E685","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"issue":"4","key":"5648_CR36","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cellsig.2013.01.013","volume":"25","author":"MA de Bittencourt Pasquali","year":"2013","unstructured":"de Bittencourt Pasquali, M. A., Gelain, D. P., Zeid\u00e1n-Chuli\u00e1, F., Pires, A. S., Gasparotto, J., Terra, S. R., & Moreira, J. C. F. (2013). Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells. Cellular Signalling, 25(4), 939\u2013954. https:\/\/doi.org\/10.1016\/j.cellsig.2013.01.013","journal-title":"Cellular Signalling"},{"key":"5648_CR37","doi-asserted-by":"publisher","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","volume":"206","author":"M Zhou","year":"2024","unstructured":"Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q. (2024). Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions - A review. Pharmacological Research, 206, 107282. https:\/\/doi.org\/10.1016\/j.phrs.2024.107282","journal-title":"Pharmacological Research"},{"issue":"24","key":"5648_CR38","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.3390\/molecules27248715","volume":"27","author":"M Yan","year":"2022","unstructured":"Yan, M., Li, X., Sun, C., Tan, J., Liu, Y., Li, M., & Wu, L. (2022). Sodium Butyrate Attenuates AGEs-Induced Oxidative Stress and Inflammation by Inhibiting Autophagy and Affecting Cellular Metabolism in THP-1 Cells. Molecules (Basel Switzerland), 27(24), 8715. https:\/\/doi.org\/10.3390\/molecules27248715","journal-title":"Molecules (Basel Switzerland)"},{"issue":"1","key":"5648_CR39","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12935-024-03545-5","volume":"24","author":"KW Tsai","year":"2024","unstructured":"Tsai, K. W., Liao, J. B., & Tseng, H. W. (2024). Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094\/miR-1270 axis. Cancer Cell International, 24(1), 384. https:\/\/doi.org\/10.1186\/s12935-024-03545-5","journal-title":"Cancer Cell International"},{"issue":"11","key":"5648_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-024-07169-5","volume":"15","author":"X Qiao","year":"2024","unstructured":"Qiao, X., Wang, Z., Chen, Y., Peng, N., Zhang, H., Niu, C., & Cheng, C. (2024). Combined metformin and simvastatin therapy inhibits SREBP2 maturation and alters energy metabolism in glioma. Cell Death & Disease, 15(11), 809. https:\/\/doi.org\/10.1038\/s41419-024-07169-5","journal-title":"Cell Death & Disease"},{"issue":"1","key":"5648_CR41","doi-asserted-by":"publisher","first-page":"119873","DOI":"10.1016\/j.bbamcr.2024.119873","volume":"1872","author":"DE Lee","year":"2025","unstructured":"Lee, D. E., Lee, H. M., Jun, Y., Choi, S. Y., Lee, S. J., & Kwon, O. S. (2025). Metformin induces apoptosis in TRAIL-resistant colorectal cancer cells. Biochimica Et Biophysica Acta Molecular Cell Research, 1872(1), 119873. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119873","journal-title":"Biochimica Et Biophysica Acta Molecular Cell Research"},{"issue":"1","key":"5648_CR42","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1038\/s41598-025-87537-z","volume":"15","author":"H Xia","year":"2025","unstructured":"Xia, H., Tai, X. J., Cheng, W., Wu, Y., He, D., Wang, L. F., & Li, X. H. (2025). Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling. Scientific Reports, 15(1), 6081. https:\/\/doi.org\/10.1038\/s41598-025-87537-z","journal-title":"Scientific Reports"},{"issue":"1","key":"5648_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/2211-5463.13314","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen, J., Qin, C., Zhou, Y., Chen, Y., Mao, M., & Yang, J. (2022). Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer. FEBS Open Bio, 12(1), 146\u2013153. https:\/\/doi.org\/10.1002\/2211-5463.13314","journal-title":"FEBS Open Bio"},{"issue":"3","key":"5648_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/abbs\/gmaa180","volume":"53","author":"Y Hou","year":"2021","unstructured":"Hou, Y., Cai, S., Yu, S., & Lin, H. (2021). Metformin induces ferroptosis by targeting miR-324-3p\/GPX4 axis in breast cancer. Acta Biochimica Et Biophysica Sinica, 53(3), 333\u2013341. https:\/\/doi.org\/10.1093\/abbs\/gmaa180","journal-title":"Acta Biochimica Et Biophysica Sinica"},{"issue":"1","key":"5648_CR45","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1038\/s41467-024-50454-2","volume":"15","author":"G Asantewaa","year":"2024","unstructured":"Asantewaa, G., Tuttle, E. T., Ward, N. P., Kang, Y. P., Kim, Y., Kavanagh, M. E., & Harris, I. S. (2024). Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression. Nature Communications, 15(1), 6152. https:\/\/doi.org\/10.1038\/s41467-024-50454-2","journal-title":"Nature Communications"},{"issue":"13","key":"5648_CR46","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang, D., Feng, Y., Zandkarimi, F., Wang, H., Zhang, Z., Kim, J., & Jiang, X. (2023). Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell, 186(13), 2748\u20132764e22. https:\/\/doi.org\/10.1016\/j.cell.2023.05.003","journal-title":"Cell"},{"issue":"2","key":"5648_CR47","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3892\/or.2019.7189","volume":"42","author":"H Yu","year":"2019","unstructured":"Yu, H., Yang, C., Jian, L., Guo, S., Chen, R., Li, K., & Liu, S. (2019). Sulfasalazine\u2013induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncology Reports, 42(2), 826\u2013838. https:\/\/doi.org\/10.3892\/or.2019.7189","journal-title":"Oncology Reports"},{"key":"5648_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40170-017-0168-x","volume":"5","author":"NJ Lanning","year":"2017","unstructured":"Lanning, N. J., Castle, J. P., Singh, S. J., Leon, A. N., Tovar, E. A., Sanghera, A., & Graveel, C. R. (2017). Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities. Cancer & Metabolism, 5, 6. https:\/\/doi.org\/10.1186\/s40170-017-0168-x","journal-title":"Cancer & Metabolism"},{"key":"5648_CR49","doi-asserted-by":"publisher","first-page":"1507942","DOI":"10.3389\/or.2024.1507942","volume":"18","author":"M Coser","year":"2024","unstructured":"Coser, M., Neamtu, B. M., Pop, B., Cipaian, C. R., & Crisan, M. (2024). RAGE and its ligands in breast cancer progression and metastasis. Oncology Reviews, 18, 1507942. https:\/\/doi.org\/10.3389\/or.2024.1507942","journal-title":"Oncology Reviews"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05648-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:29:56Z","timestamp":1782098996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05648-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05648-3","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"24 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Xuzhou Central Hospital (Approval No: XZXY-LK-20240426-0067, Approval Date: April 26, 2024. Retrospectively Registration). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients who had granted written informed consent, personally or via their immediate family members, were eligible for immunohistochemical staining.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors confirm that patients provided written informed consent for the publication of the immunohistochemical images presented in Fig.\u00a01C.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}